Source: Institutional Research Information System (IRIS)
Ribero, Simone; Lambertini, Martina; Ferracin, Manuela; Dika, Emi, Non-Coding RNA Investigations in Cutaneous Melanoma: A Step forward in Discovering Novel Biomarkers, «JOURNAL OF INVESTIGATIVE DERMATOLOGY», 2023, 143, pp. 531 - 532 [Scientific article]
Fontana, Beatrice; Gallerani, Giulia; Salamon, Irene; Pace, Ilaria; Roncarati, Roberta; Ferracin, Manuela, ARID1A in cancer: Friend or foe?, «FRONTIERS IN ONCOLOGY», 2023, 13, pp. 1 - 10 [Scientific article] Open Access
Filippini, Daria Maria; Broseghini, Elisabetta; Carosi, Francesca; Molin, Davide Dal; Riefolo, Mattia; Fabbri, Laura; Abeshi, Andi; Fernandez, Ignacio Javier; Ferracin, Manuela, A Systematic Review of Diagnostic and Prognostic Biomarkers for Head and Neck Cancer of Unknown Primary: An Unmet Clinical Need, «DIAGNOSTICS», 2023, 13, pp. 1 - 16 [Scientific article] Open Access
Bergamini, Christian; Leoni, Ilaria; Rizzardi, Nicola; Melli, Mattia; Galvani, Giuseppe; Coada, Camelia Alexandra; Giovannini, Catia; Monti, Elisa; Liparulo, Irene; Valenti, Francesca; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca, MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma, «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH», 2023, 42, pp. 1 - 23 [Scientific article] Open Access
Ditaranto, Raffaello; Leone, Ornella; Lovato, Luigi; Niro, Fabio; Cenacchi, Giovanna; Papa, Valentina; Baldovini, Chiara; Ferracin, Manuela; Salamon, Irene; Kurdi, Hibba; Parisi, Vanda; Capelli, Irene; Pession, Andrea; Liguori, Rocco; Potena, Luciano; Seri, Marco; Martin Suarez, Sofia; Galiè, Nazzareno; Moon, James C; Biagini, Elena, Correlations Between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry Disease, «JACC. CARDIOVASCULAR IMAGING», 2023, 16, pp. 1629 - 1632 [Scientific article] Open Access
Gallerani G.; Rossi T.; Ferracin M.; Bonafe' M., Settling the uncertainty about unconventional circulating tumor cells: Epithelial-to-mesenchymal transition, cell fusion and trogocytosis, in: Circulating Tumor Cells, From Biotech Innovation to Clinical Utility, Amsterdam, Elsevier Inc., 2023, pp. 99 - 111 (INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY) [Chapter or essay]
Dragomir M.P.; Fuentes-Mattei E.; Winkle M.; Okubo K.; Bayraktar R.; Knutsen E.; Qdaisat A.; Chen M.; Li Y.; Shimizu M.; Pang L.; Liu K.; Liu X.; Anfossi S.; Zhang H.; Koch I.; Tran A.M.; Mohapatra S.; Ton A.; Kaplan M.; Anderson M.W.; Rothfuss S.J.; Silasi R.; Keshari R.S.; Ferracin M.; Ivan C.; Rodriguez-Aguayo C.; Lopez-Berestein G.; Georgescu C.; Banerjee P.P.; Basar R.; Li Z.; Horst D.; Vasilescu C.; Bertilaccio M.T.S.; Rezvani K.; Lupu F.; Yeung S.-C.; Calin G.A., Anti–miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response, «THE JOURNAL OF CLINICAL INVESTIGATION», 2023, 133, pp. 1 - 18 [Scientific article] Open Access
Ruggieri F.; Jonas K.; Ferracin M.; Dengler M.; Jӓger V.; Pichler M., MicroRNAs as regulators of tumor metabolism, «ENDOCRINE-RELATED CANCER», 2023, 30, pp. 220267 - 220267 [Scientific article]
Untergasser A.; Hellemans J.; Pfaffl M.W.; Ruijter J.M.; van den Hoff M.J.B.; Dragomir M.P.; Adamoski D.; Dias S.M.G.; Reis R.M.; Ferracin M.; Dias-Neto E.; Marsh I.; Kubista M.; Fabbri M.; Goel A.; Slaby O.; Knutsen E.; Chen B.; Negrini M.; Mimori K.; Pichler M.; Papatriantafyllou M.; Anfossi S.; Schmittgen T.D.; Huggett J.; Bustin S.; Vandesompele J.; Calin G.A., Disclosing quantitative RT-PCR raw data during manuscript submission: a call for action, «MOLECULAR ONCOLOGY», 2023, 17, pp. 713 - 717 [Scientific article] Open Access
Jonas K.; Prinz F.; Ferracin M.; Krajina K.; Pasculli B.; Deutsch A.; Madl T.; Rinner B.; Slaby O.; Klec C.; Pichler M., MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib, «BREAST CANCER RESEARCH», 2023, 25, pp. 1 - 17 [Scientific article] Open Access